Jump to navigation Jump to search
- An oral nucleotide-analogue reverse transcriptase inhibitor used to treat hepatitis B.
- 2009 October 11, Amy Zipkin, “On the Discovery Trail”, in New York Times:
- I joined Gilead Sciences in 1990, and by 1999 we were in the final stage of about five or six years of work in creating the drug adefovir dipivoxil to treat H.I.V. The drug wasn’t approved by the F.D.A. for H.I.V. because the data showed evidence of kidney toxicity.